Parkin et al. reported a detailed investigation in 95 AML patients and showed that 10 out of 95 (10.5%) had heterozygous deletions of the NF1 locus, a lower percentage than our study (13/55, 26.5%)[14]. Here, NF1 is linked to acute myeloid leukemia.